Renovaro (RENB) News Today $0.81 -0.01 (-0.75%) As of 01:32 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Renovaro BioSciences appoints Fuentes as Chief Financial OfficerJanuary 7, 2025 | markets.businessinsider.comRenovaro BioSciences issues shareholder letter, provides corporate updateJanuary 7, 2025 | markets.businessinsider.comPREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAIJanuary 7, 2025 | businesswire.comRenovaro Biosciences Merges with Predictive OncologyJanuary 7, 2025 | tipranks.comRenovaro Inc. Appoints Nathen Fuentes As CFOJanuary 7, 2025 | markets.businessinsider.comRenovaro Inc: Renovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | finanznachrichten.deRenovaro Taps Nathen Fuentes as Finance ChiefJanuary 7, 2025 | marketwatch.comPredictive Oncology to be acquired by RenovaroJanuary 7, 2025 | markets.businessinsider.comRenovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | finance.yahoo.comRenovaro Issues Shareholder Letter and Provides Corporate UpdateJanuary 7, 2025 | globenewswire.comRenovaro Appoints Nathen Fuentes as Chief Financial OfficerJanuary 7, 2025 | globenewswire.comRenovaro to Acquire Predictive Oncology in All-Stock TransactionJanuary 6, 2025 | tmcnet.comRenovaro to Acquire Predictive Oncology in All-Stock TransactionJanuary 6, 2025 | globenewswire.comRenovaro Inc. (NASDAQ:RENB) Short Interest Up 27.7% in DecemberRenovaro Inc. (NASDAQ:RENB - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 3,870,000 shares, a growth of 27.7% from the November 30th total of 3,030,000 shares. Based on an average trading volume of 869,400 shares, the days-to-cover ratio is presently 4.5 days. Currently, 5.0% of the company's stock are sold short.December 31, 2024 | marketbeat.comRenovaro BioSciences appoints Maurice van Tilburg as CEO of GEDi CubeDecember 31, 2024 | markets.businessinsider.comRenovaro Inc. Appoints Maurice van Tilburg as CEO of GEDi Cube BV to Enhance AI-Driven Cancer DiagnosticsDecember 30, 2024 | quiverquant.comRenovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BVDecember 30, 2024 | globenewswire.comRenovaro BioSciences receives approval of Lumina projectDecember 23, 2024 | markets.businessinsider.comRenovaroCube Receives Approval of Lumina Project by the Eurostars Funding ProgramDecember 23, 2024 | globenewswire.comRenovaro Regains Compliance with NASDAQ Listing RequirementDecember 20, 2024 | globenewswire.comRenovaro Inc: Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease DetectionDecember 20, 2024 | finanznachrichten.deRenovaro werkt samen met Nebul voor AI-gestuurde kankerdetectieDecember 20, 2024 | nl.investing.comRenovaro BioSciences enters into strategic collaboration with NebulDecember 20, 2024 | markets.businessinsider.comRenovaro Inc. Partners with Nebul to Launch GEDi CUBE Next Generation AI Healthcare Cloud SolutionsDecember 20, 2024 | quiverquant.comRenovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease DetectionDecember 20, 2024 | globenewswire.comRenovaro (NASDAQ:RENB) Stock Price Up 2.3% - Here's What HappenedRenovaro (NASDAQ:RENB) Stock Price Up 2.3% - Time to Buy?December 14, 2024 | marketbeat.comRenovaro (NASDAQ:RENB) Trading Up 6.5% - Still a Buy?Renovaro (NASDAQ:RENB) Trading 6.5% Higher - Still a Buy?November 21, 2024 | marketbeat.comRenovaro BioSciences issues shareholder letterNovember 5, 2024 | markets.businessinsider.comRenovaro benoemt nieuwe CEO om kankertechnologie te bevorderenNovember 4, 2024 | nl.investing.comRenovaro Issues Shareholder Letter and Provides Corporate UpdateNovember 4, 2024 | globenewswire.comRenovaro BioSciences files $200M mixed securities shelfOctober 31, 2024 | markets.businessinsider.comRenovaro Names Weinstein as CEO; Four New Board AppointmentsOctober 18, 2024 | marketwatch.comRenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore SequencingOctober 17, 2024 | globenewswire.comRenovaro Inc: Renovaro Announces Strategic Restructuring and Leadership TransitionOctober 17, 2024 | finanznachrichten.deRenovaro Announces Strategic Restructuring and Leadership TransitionOctober 16, 2024 | globenewswire.comRenovaro (NASDAQ:RENB) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comPersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care DiagnosticsSeptember 19, 2024 | markets.businessinsider.comIndependent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer DetectionSeptember 18, 2024 | markets.businessinsider.comRenovaro seeks strategic investors for subsidiary CubeSeptember 13, 2024 | uk.investing.comRenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology CongressSeptember 13, 2024 | globenewswire.comRenovaro Inc: RenovaroCube Announces Strategic Offering of Up to 20% OwnershipSeptember 11, 2024 | finanznachrichten.deRenovaro zoekt strategische investeerders voor dochteronderneming CubeSeptember 11, 2024 | nl.investing.comRenovaro To Seek Funds From Strategic Investors To Acquire Up To 20% Of RenovaroCubeSeptember 11, 2024 | markets.businessinsider.comRenovaroCube Announces Strategic Offering of Up to 20% OwnershipSeptember 11, 2024 | globenewswire.comRENB Sep 2024 2.000 call (RENB240920C00002000)August 17, 2024 | finance.yahoo.comVanguard Group Inc. Grows Stock Holdings in Renovaro Inc. (NASDAQ:RENB)Vanguard Group Inc. lifted its position in Renovaro Inc. (NASDAQ:RENB - Free Report) by 904.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,916,672 shares of the company's stock after buying an additionaAugust 15, 2024 | marketbeat.comRenovaro Inc RENBJuly 25, 2024 | morningstar.comInsider Selling: Renovaro Inc. (NASDAQ:RENB) Major Shareholder Sells 16,362 Shares of StockJuly 20, 2024 | insidertrades.comRenovaro Inc. (NASDAQ:RENB) Major Shareholder Sells $23,888.52 in StockRenovaro Inc. (NASDAQ:RENB - Get Free Report) major shareholder Anderson Wittekind William sold 16,362 shares of Renovaro stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $1.46, for a total value of $23,888.52. Following the completion of the transaction, the insider now owns 841,433 shares in the company, valued at $1,228,492.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.July 19, 2024 | marketbeat.comAnderson Wittekind William Sells 21,954 Shares of Renovaro Inc. (NASDAQ:RENB) StockJuly 18, 2024 | insidertrades.com Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address RENB Media Mentions By Week RENB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENB News Sentiment▼0.440.76▲Average Medical News Sentiment RENB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENB Articles This Week▼21▲RENB Articles Average Week Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kura Oncology News Tectonic Therapeutic News CARGO Therapeutics News Humacyte News Annexon News Pharvaris News Keros Therapeutics News Mereo BioPharma Group News Rapport Therapeutics News Ginkgo Bioworks News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RENB) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Renovaro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RENB Stock Alerts